Muscle Damage in Dystrophic mdx Mice Is Influenced by the Activity of Ca2+-Activated KCa3.1 Channels
Authors:
- Marta MorottiMMMarta Morotti
- Stefano GarofaloSGStefano Garofalo
- Germana CocozzaGCGermana Cocozza
- Fabrizio AntonangeliFAFabrizio Antonangeli
- Valeria BianconiVBValeria Bianconi
- Chiara MozzettaCMChiara Mozzetta
- Maria Egle De StefanoMaria Egle De Stefano
- Riccardo CapitaniRiccardo Capitani
- Heike WulffHWHeike Wulff
- Cristina LimatolaCLCristina Limatola
- Myriam CatalanoMCMyriam Catalano
- Francesca GrassiFrancesca Grassi
Open Access
Abstract
Duchenne muscular dystrophy (DMD) is an X-linked disease, caused by a mutant dystrophin gene, leading to muscle membrane instability, followed by muscle inflammation, infiltration of pro-inflammatory macrophages and fibrosis. The calcium-activated potassium channel type 3.1 (KCa3.1) plays key roles in controlling both macrophage phenotype and fibroblast proliferation, two critical contributors to muscle damage. In this work, we demonstrate that pharmacological blockade of the channel in the mdx mouse model during the early degenerative phase favors the acquisition of an anti-inflammatory phenotype by tissue macrophages and reduces collagen deposition in muscles, with a concomitant reduction of muscle damage. As already observed with other treatments, no improvement in muscle performance was observed in vivo. In conclusion, this work supports the idea that KCa3.1 channels play a contributing role in controlling damage-causing cells in DMD. A more complete understanding of their function could lead to the identification of novel therapeutic approaches.Keywords
Funding Information
- Sapienza Università di Roma (RP1201727EA43399)
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN20178L7WRS, PRIN2020Z73J5A)
- Fondazione Italiana per la Ricerca sul Cancro (IG-23010)
- Duchenne Parent Project Netherlands (small grant proposal ref. 19.006)
This publication has 54 references indexed in Scilit:
- Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regenerationThe FEBS Journal, 2013
- The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion StrokeJournal of Cerebral Blood Flow & Metabolism, 2011
- Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF‐β1 blockerMuscle & Nerve, 2010
- Therapeutic potential of KCa3.1 blockers: recent advances and promising trendsExpert Review of Clinical Pharmacology, 2010
- Renal fibrosis is attenuated by targeted disruption of K Ca 3.1 potassium channelsProceedings of the National Academy of Sciences, 2009
- Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophyHuman Molecular Genetics, 2008
- Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginoneNeuromuscular Disorders, 2008
- Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic statesNature Medicine, 2007
- Weekly oral prednisolone improves survival and strength in male mdx miceMuscle & Nerve, 2006
- Inhibition of proliferation in 8-week-old mdx mouse muscle fibroblasts in vitroDifferentiation, 1995